PAB Patrys Completes $3.5M Placement 16/05/18 PRICE SENSITIVE download Created with Sketch. 99.71KB Share PAB Trading Halt 14/05/18 PRICE SENSITIVE download Created with Sketch. 266.61KB Share PAB Appendix 4C - Quarterly - 31 March 2018 27/04/18 PRICE SENSITIVE download Created with Sketch. 306.6KB Share PAB Patrys Receives R&D Tax Incentive Refund 05/04/18 PRICE SENSITIVE download Created with Sketch. 100.95KB Share PAB PAT-DX1 Improves Survival in Animal Model of Glioblastoma 19/03/18 PRICE SENSITIVE download Created with Sketch. 246.2KB Share PAB PAT-DX1 Crosses Blood Brain Barrier to Reduce Tumour Size 28/02/18 PRICE SENSITIVE download Created with Sketch. 139.11KB Share PAB Appendix 4D - Half Year Accounts - 31 December 2017 23/02/18 PRICE SENSITIVE download Created with Sketch. 707.08KB Share PAB Appendix 4C - Quarterly - 31 December 2017 31/01/18 PRICE SENSITIVE download Created with Sketch. 306.28KB Share PAB Publication and Patent Filing for Humanized Version of 3E10 30/01/18 PRICE SENSITIVE download Created with Sketch. 144.28KB Share PAB PAT-DX1-NP Localizes to Lymph Node Metastases 29/01/18 PRICE SENSITIVE download Created with Sketch. 235.72KB Share PAB PAT-DX1 Targets Nanoparticles to Breast Cancer 29/01/18 PRICE SENSITIVE download Created with Sketch. 235.96KB Share PAB Entitlement Offer Booklet 15/01/18 PRICE SENSITIVE download Created with Sketch. 1.79MB Share PAB $2.4 Million Fully Underwritten Rights Issue 15/01/18 PRICE SENSITIVE download Created with Sketch. 151.14KB Share PAB Trading Halt 11/01/18 PRICE SENSITIVE download Created with Sketch. 491.31KB Share PAB PAT-DX1 is synergistic with PARP inhibitor 11/12/17 PRICE SENSITIVE download Created with Sketch. 242.61KB Share PAB Collaboration with WEHI 16/11/17 PRICE SENSITIVE download Created with Sketch. 237.83KB Share PAB Appendix 4C - Quarterly - 30 September 2017 27/10/17 PRICE SENSITIVE download Created with Sketch. 200.91KB Share PAB PAB and Garvan Institute of Medical Research Awarded Grant 16/10/17 PRICE SENSITIVE download Created with Sketch. 685.46KB Share PAB US Patent Granted for Preclinical Candidate PAT-LM1 11/10/17 PRICE SENSITIVE download Created with Sketch. 543.76KB Share PAB PAT-DX1 Conjugated to Nanoparticles, Targets Tumors 18/09/17 PRICE SENSITIVE download Created with Sketch. 231.85KB Share PAB PAT-DX1 Active in Pre-clinical Cancer Models 14/09/17 PRICE SENSITIVE download Created with Sketch. 242.9KB Share PAB Appendix 4E and 2017 Annual Report 29/08/17 PRICE SENSITIVE download Created with Sketch. 1.08MB Share PAB Appendix 4C - Quarterly - 30 June 2017 26/07/17 PRICE SENSITIVE download Created with Sketch. 580.52KB Share PAB Patrys' Deoxymab 3E10 patent granted in the U.S. 12/07/17 PRICE SENSITIVE download Created with Sketch. 461.81KB Share PAB PAB Licences Deoxymab 3E10 - nanoparticle IP from Yale 13/06/17 PRICE SENSITIVE download Created with Sketch. 247.59KB Share PAB Finance Update 01/05/17 PRICE SENSITIVE download Created with Sketch. 323.74KB Share PAB Appendix 4C - Quarterly - 31 March 2017 27/04/17 PRICE SENSITIVE download Created with Sketch. 172.38KB Share PAB Deoxymab 3E10 lead candidate confirmed 19/04/17 PRICE SENSITIVE download Created with Sketch. 116.16KB Share PAB Appendix 4D - Half Year Accounts - 31 December 2016 23/02/17 PRICE SENSITIVE download Created with Sketch. 1.13MB Share PAB Appendix 4C - Quarterly - 31 December 2016 17/01/17 PRICE SENSITIVE download Created with Sketch. 170.29KB Share PAB Appendix 4C - Quarterly - 30 September 2016-PAB.AX 28/10/16 PRICE SENSITIVE download Created with Sketch. 285.35KB Share PAB Response to ASX Price Query-PAB.AX 27/10/16 PRICE SENSITIVE download Created with Sketch. 601.55KB Share PAB Market Update-PAB.AX 13/09/16 PRICE SENSITIVE download Created with Sketch. 447.92KB Share PAB Appendix 4E and 2016 Annual Report-PAB.AX 30/08/16 PRICE SENSITIVE download Created with Sketch. 810.06KB Share PAB Appendix 4C - Quarterly - 30 June 2016-PAB.AX 28/07/16 PRICE SENSITIVE download Created with Sketch. 100.42KB Share PAB Appendix 4C - Quarterly - 31 March 2016-PAB.AX 21/04/16 PRICE SENSITIVE download Created with Sketch. 183.73KB Share PAB Publication on PAT-SM6 Combination Therapy-PAB.AX 05/04/16 PRICE SENSITIVE download Created with Sketch. 546.91KB Share PAB Patrys Acquires Novel Assets from Yale University 29/03/16 PRICE SENSITIVE download Created with Sketch. 394.9KB Share PAB Appendix 4D - Half Year Accounts - 31 December 2015 24/02/16 PRICE SENSITIVE download Created with Sketch. 933.25KB Share PAB Appendix 4C - Quarterly - 31 December 2015 29/01/16 PRICE SENSITIVE download Created with Sketch. 50.51KB Share PAB Appendix 4C - Quarterly - 30 September 2015 27/10/15 PRICE SENSITIVE download Created with Sketch. 95.21KB Share PAB Market Update 29/09/15 PRICE SENSITIVE download Created with Sketch. 470.85KB Share PAB Response to ASX Price Query 18/09/15 PRICE SENSITIVE download Created with Sketch. 555.65KB Share PAB Preliminary Final Report - 30 June 2015 28/08/15 PRICE SENSITIVE download Created with Sketch. 841.25KB Share PAB Appendix 4C - Quarterly - 30 June 2015 14/07/15 PRICE SENSITIVE download Created with Sketch. 57.74KB Share PAB Patrys to License Chinese Rights for PAT-SC1 25/06/15 PRICE SENSITIVE download Created with Sketch. 439.32KB Share PAB Manufacturing Update - Clinical Trial Remains on Hold 11/06/15 PRICE SENSITIVE download Created with Sketch. 355.27KB Share PAB Appendix 4C - Quarterly - 31 March 2015 20/04/15 PRICE SENSITIVE download Created with Sketch. 156.68KB Share PAB Patrys Appoints Dr. James Campbell as CEO 08/04/15 PRICE SENSITIVE download Created with Sketch. 441.93KB Share PAB Appendix 4D - Half Year Accounts - 31 December 2014 25/02/15 PRICE SENSITIVE download Created with Sketch. 734.43KB Share PAB Patrys Granted European Patent for PAT-SM6 18/02/15 PRICE SENSITIVE download Created with Sketch. 98.65KB Share PAB Patrys Provides Market Update 06/02/15 PRICE SENSITIVE download Created with Sketch. 90.29KB Share PAB PAT-SM6 Phase I/IIa Multiple Myeloma Trial Results Published 04/02/15 PRICE SENSITIVE download Created with Sketch. 436.15KB Share PAB Appendix 4C - Quarterly - 31 December 2014 09/01/15 PRICE SENSITIVE download Created with Sketch. 157.96KB Share PAB Patrys Provides Update on Clinical Trial 07/11/14 PRICE SENSITIVE download Created with Sketch. 426.23KB Share PAB Patrys Provides Update on CEO Position 29/10/14 PRICE SENSITIVE download Created with Sketch. 416.77KB Share PAB Appendix 4C - Quarterly - 30 September 2014 17/10/14 PRICE SENSITIVE download Created with Sketch. 157.58KB Share PAB Patrys Granted Australian Patent for PAT-LM1 30/09/14 PRICE SENSITIVE download Created with Sketch. 359.8KB Share PAB Patrys CEO Resignation 24/09/14 PRICE SENSITIVE download Created with Sketch. 334.26KB Share PAB Patrys Limited - Open Briefing 16/09/14 PRICE SENSITIVE download Created with Sketch. 274.54KB Share PAB Preliminary Final Report - 30 June 2014 29/08/14 PRICE SENSITIVE download Created with Sketch. 674.61KB Share PAB Patrys - Details of PAT-SM6 & Carfilzomib Clinical Trial 25/08/14 PRICE SENSITIVE download Created with Sketch. 370.28KB Share PAB Patrys to Present at German Hematology Congress 18/08/14 PRICE SENSITIVE download Created with Sketch. 124.94KB Share PAB Patrys Reports Progress on Preclinical Programmes 24/07/14 PRICE SENSITIVE download Created with Sketch. 476.88KB Share PAB Appendix 4C - Quarterly Cash Flow - June 2014 21/07/14 PRICE SENSITIVE download Created with Sketch. 156.5KB Share PAB Patrys Granted Third US Patent for PAT-SM6 18/06/14 PRICE SENSITIVE download Created with Sketch. 477.49KB Share PAB Positive Response for PAT-SM6 in Combination Therapy 28/05/14 PRICE SENSITIVE download Created with Sketch. 371.59KB Share PAB Appendix 4C - Quarterly Cash Flow - March 2014 11/04/14 PRICE SENSITIVE download Created with Sketch. 156.81KB Share PAB First Plant-based Production of PAT-SM6 02/04/14 PRICE SENSITIVE download Created with Sketch. 511.31KB Share PAB Final Data Confirms Successful PAT-SM6 Clinical Trial 27/03/14 PRICE SENSITIVE download Created with Sketch. 378.18KB Share PAB PAT-LM1 Advancing to the Clinic 24/03/14 PRICE SENSITIVE download Created with Sketch. 383.58KB Share PAB Half Yearly Report and Accounts - December 2013 12/02/14 PRICE SENSITIVE download Created with Sketch. 856.34KB Share PAB Patrys Provides Shareholder Update 23/01/14 PRICE SENSITIVE download Created with Sketch. 490.29KB Share PAB PAT-SC1 Clinical Trial 10 Year Follow Up Data Published 22/01/14 PRICE SENSITIVE download Created with Sketch. 366.1KB Share PAB Appendix 4C - Quarterly Cash Flow - December 2013 21/01/14 PRICE SENSITIVE download Created with Sketch. 156.59KB Share PAB Patrys Raises a Further $1.3 Million 14/01/14 PRICE SENSITIVE download Created with Sketch. 911.84KB Share PAB Data from Final Cohort of Patients in MM Clinical Trial 29/11/13 PRICE SENSITIVE download Created with Sketch. 483.66KB Share PAB Rights Issue Offer Document 27/11/13 PRICE SENSITIVE download Created with Sketch. 462.17KB Share PAB Patrys Granted Australian Patent for PAT-SM6 18/11/13 PRICE SENSITIVE download Created with Sketch. 365.15KB Share PAB Patrys Announces $12.5 Million Rights Issue 13/11/13 PRICE SENSITIVE download Created with Sketch. 408.37KB Share PAB Patrys to Initiate Clinical Trial with Onyx Pharmaceuticals 11/11/13 PRICE SENSITIVE download Created with Sketch. 469.72KB Share PAB Patrys Granted US Patent for Lead Product PAT-LM1 08/11/13 PRICE SENSITIVE download Created with Sketch. 355.39KB Share PAB USA FDA Grants Orphan Drug Status for PAT-SM6 06/11/13 PRICE SENSITIVE download Created with Sketch. 361.86KB Share PAB Appendix 4C - Quarterly Cash Flow - September 2013 18/10/13 PRICE SENSITIVE download Created with Sketch. 34.88KB Share PAB PAT-SM6 Receives Orphan Drug Designation for MM 12/09/13 PRICE SENSITIVE download Created with Sketch. 379.27KB Share PAB Appendix 4E and 2013 Annual Report 21/08/13 PRICE SENSITIVE download Created with Sketch. 3.66MB Share PAB Data from 2nd and 3rd Cohorts in Multiple Myeloma Trial 13/08/13 PRICE SENSITIVE download Created with Sketch. 369.56KB Share PAB Patrys' MM Clinical Trial to Progress to Final Patient Group 07/08/13 PRICE SENSITIVE download Created with Sketch. 362.31KB Share PAB Treatment of 3rd Patient Group in MM Trial Completed 24/07/13 PRICE SENSITIVE download Created with Sketch. 362.9KB Share PAB Appendix 4C - Quarterly Cash Flow - June 2013 19/07/13 PRICE SENSITIVE download Created with Sketch. 156.71KB Share PAB ARC Linkage Grant to Support PAT-SM6 Diagnostics Development 10/07/13 PRICE SENSITIVE download Created with Sketch. 276.96KB Share PAB Further Data on the Effectiveness of PAT-SM6 Published 11/06/13 PRICE SENSITIVE download Created with Sketch. 613.03KB Share PAB Patrys Granted Key Patent for Lead Product PAT-LM1 06/06/13 PRICE SENSITIVE download Created with Sketch. 449.26KB Share PAB PAT-SM6 Kills Human Multiple Myeloma Cells 08/05/13 PRICE SENSITIVE download Created with Sketch. 483.55KB Share PAB Patrys Progresses MM Clinical Trial to 3rd Patient Group 24/04/13 PRICE SENSITIVE download Created with Sketch. 360.14KB Share PAB New Data Supports PAT-SM6 Profile as Anti-cancer Treatment 22/04/13 PRICE SENSITIVE download Created with Sketch. 379.63KB Share PAB Appendix 4C - Quarterly Cash Flow - March 2013 19/04/13 PRICE SENSITIVE download Created with Sketch. 157.13KB Share PAB Treatment of Second Patient Group in MM Trial Completed 10/04/13 PRICE SENSITIVE download Created with Sketch. 360.14KB Share PAB Preclinical Results Support PAT-SM6 MM Programme 20/03/13 PRICE SENSITIVE download Created with Sketch. 475.09KB Share PAB Data from 1st Cohort in Multiple Myeloma Trial 07/03/13 PRICE SENSITIVE download Created with Sketch. 366.4KB Share
(20min delay)
